SUNDAY June 1, 2014, 2014 — Adding the chemotherapy drug docetaxel to standard hormone-depleting therapy may extend the lives of men with advanced prostate cancer, a new study finds. The study was to be presented Sunday in Chicago at the annual meeting of the American Society of Clinical…
Source:New Approach May Boost Survival From Advanced Prostate Cancer
Sunday, June 1, 2014
New Approach May Boost Survival From Advanced Prostate Cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment